IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,307 Cr | ₹2,384 Cr | ₹2,356 Cr | ₹1,806 Cr | ₹1,466 Cr |
What is the latest Total Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹2,307 Cr |
| Mar2025 | ₹2,384 Cr |
| Mar2024 | ₹2,356 Cr |
| Mar2023 | ₹1,806 Cr |
| Mar2022 | ₹1,466 Cr |
How is Total Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,307 Cr | -3.24 | |
| Mar2025 | ₹2,384 Cr | 1.22 | |
| Mar2024 | ₹2,356 Cr | 30.45 | |
| Mar2023 | ₹1,806 Cr | 23.19 | |
| Mar2022 | ₹1,466 Cr | - | |
Compare Total Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹49,966.2 Cr | 0.5% | 9.6% | 49.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 0.5% |
9.6% |
49.3% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses